Cargando…

Antibiotic Minocycline Prevents Respiratory Syncytial Virus Infection

Treatment drugs, besides their specific activity, often have multiple effects on the body. The undesired effect of the drug may be repurposed as therapeutics, saving significant investigative time and effort. Minocycline has anti-cancer, anti-oxidant, anti-inflammatory, and anti-apoptotic properties...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bawage, Swapnil S., Tiwari, Pooja M., Pillai, Shreekumar, Dennis, Vida A., Singh, Shree R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6723987/ https://www.ncbi.nlm.nih.gov/pubmed/31405261 http://dx.doi.org/10.3390/v11080739

Ejemplares similares

Recent Advances in Diagnosis, Prevention, and Treatment of Human Respiratory Syncytial Virus
por: Bawage, Swapnil Subhash, et al.
Publicado: (2013)

Immunogenicity of RSV F DNA Vaccine in BALB/c Mice
por: Eroglu, Erdal, et al.
Publicado: (2016)

Facile and rapid detection of respiratory syncytial virus using metallic nanoparticles
por: Valdez, Jesus, et al.
Publicado: (2016)

Engineered mRNA-expressed antibodies prevent respiratory syncytial virus infection
por: Tiwari, Pooja Munnilal, et al.
Publicado: (2018)

Novel cationic peptide TP359 down-regulates the expression of outer membrane biogenesis genes in Pseudomonas aeruginosa: a potential TP359 anti-microbial mechanism
por: Dosunmu, Ejovwoke F., et al.
Publicado: (2016)

Anti-RSV Peptide-Loaded Liposomes for the Inhibition of Respiratory Syncytial Virus †
por: Joshi, Sameer, et al.
Publicado: (2018)

Silver-coated carbon nanotubes downregulate the expression of Pseudomonas aeruginosa virulence genes: a potential mechanism for their antimicrobial effect
por: Dosunmu, Ejovwoke, et al.
Publicado: (2015)

The prevention of respiratory syncytial virus infection
por: Bollani, L, et al.
Publicado: (2014)

Advances in Skin Regeneration Using Tissue Engineering
por: Vig, Komal, et al.
Publicado: (2017)

Future Prospects for Scaffolding Methods and Biomaterials in Skin Tissue Engineering: A Review
por: Chaudhari, Atul A., et al.
Publicado: (2016)

Epidemiology and prevention of respiratory syncytial virus infections in children in Italy
por: Azzari, Chiara, et al.
Publicado: (2021)

The anti-microbial peptide TP359 attenuates inflammation in human lung cells infected with Pseudomonas aeruginosa via TLR5 and MAPK pathways
por: Dosunmu, Ejovwoke F., et al.
Publicado: (2017)

Immunological challenges associated with artificial skin grafts: available solutions and stem cells in future design of synthetic skin
por: Dixit, Saurabh, et al.
Publicado: (2017)

Respiratory syncytial virus: diagnosis, prevention and management
por: Barr, Rachael, et al.
Publicado: (2019)

Severe Respiratory Syncytial Virus Infection
por: Kashiwagi, Yasuyo, et al.
Publicado: (2019)

Diagnosis of Respiratory Syncytial Virus Infection
por: Popow-Kraupp, Therese, et al.
Publicado: (2011)

Respiratory Syncytial Virus Infection and Bronchiolitis
por: Piedimonte, Giovanni, et al.
Publicado: (2014)

The Use of Humanized Monoclonal Antibodies for the Prevention of Respiratory Syncytial Virus Infection
por: Lanari, Marcello, et al.
Publicado: (2013)

Neutrophils in respiratory syncytial virus infection: A target for asthma prevention
por: Geerdink, Ruben J., et al.
Publicado: (2015)

Respiratory Syncytial Virus and Other Pediatric Respiratory Virus Infections
por: L., G.
Publicado: (1998)

Receptors for Respiratory Syncytial Virus Infection and Host Factors Regulating the Life Cycle of Respiratory Syncytial Virus
por: Feng, Ziheng, et al.
Publicado: (2022)

Functionalized Gold Nanoparticles and Their Biomedical Applications
por: Tiwari, Pooja M., et al.
Publicado: (2011)

The Future of Respiratory Syncytial Virus Disease Prevention and Treatment
por: Domachowske, Joseph B., et al.
Publicado: (2021)

Prevention and Treatment Strategies for Respiratory Syncytial Virus (RSV)
por: Gatt, Dvir, et al.
Publicado: (2023)

Respiratory Syncytial Virus
por: Fraire, Armando E., et al.
Publicado: (2013)

Respiratory syncytial virus
por: Ruuskanen, Olli, et al.
Publicado: (1993)

Respiratory syncytial virus
por: Munoz, Flor M., et al.
Publicado: (2020)

Product review on the monoclonal antibody palivizumab for prevention of respiratory syncytial virus infection
por: Resch, Bernhard
Publicado: (2017)

Suptavumab for the Prevention of Medically Attended Respiratory Syncytial Virus Infection in Preterm Infants
por: Simões, Eric A F, et al.
Publicado: (2020)

Effectiveness of palivizumab in preventing respiratory syncytial virus infection in high-risk children
por: Viguria, Natividad, et al.
Publicado: (2021)

Respiratory syncytial virus infection: an innate perspective
por: Johansson, Cecilia
Publicado: (2016)

Animal models of respiratory syncytial virus infection
por: Taylor, Geraldine
Publicado: (2017)

Respiratory Syncytial Virus Infection in Elderly Adults
por: Falsey, Ann R., et al.
Publicado: (2012)

Host Responses to Respiratory Syncytial Virus Infection
por: Agac, Ayse, et al.
Publicado: (2023)

The Changing Landscape of Respiratory Syncytial Virus Infections
por: Bem, Reinout A., et al.
Publicado: (2023)

Pharyngeal Microflora Disruption by Antibiotics Promotes Airway Hyperresponsiveness after Respiratory Syncytial Virus Infection
por: Ni, Ke, et al.
Publicado: (2012)

Prevention and treatment of respiratory syncytial virus bronchiolitis and postbronchiolitic wheezing
por: Kimpen, Jan LL
Publicado: (2002)

Antibody development for preventing the human respiratory syncytial virus pathology
por: Soto, Jorge A., et al.
Publicado: (2020)

Respiratory Syncytial Virus Prevention: A New Era of Vaccines
por: Lee, Calvin Yee Fen, et al.
Publicado: (2023)

Past, Present and Future Approaches to the Prevention and Treatment of Respiratory Syncytial Virus Infection in Children
por: Simões, Eric A. F., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_gj7tjj4e6j1jbvqtfjbk91vq4m